Skip to main content
. Author manuscript; available in PMC: 2012 Jun 1.
Published in final edited form as: Bioorg Med Chem Lett. 2011 Apr 5;21(11):3423–3426. doi: 10.1016/j.bmcl.2011.03.110

Figure 2.

Figure 2

A, B and C: Representative coronal microPET images of the U87MG tumor-bearing mice at different time points (1, 4, 18 or 25 h) post-injection of 64Cu-DOTA-P1, 64Cu-DOTA-P2, and 64Cu-DOTA-P3, respectively (arrows indicate tumors). D, E, and F: MicroPET quantification results, expressed as percentage of injected dose per gram (%ID/g), in different organs and tumor of subcutaneous U87MG glioblastoma xenograft model after intravenous injection of 64Cu-DOTA-P1, 64Cu-DOTA-P2, and 64Cu-DOTA-P3, respectively.